Exsurco Medical's Swasita Saigal to Present at the Upcoming Compliance Training Conference

June 2019

Congratulations to Swasita Saigal, Director of Regulatory Affairs and Corporate Compliance at Exsurco Medical, for being selected as a presenter at the 4th Annual Life Science Ethics and Compliance Training Conference in Chicago, June 5-6th, 2019.

About the Conference:
Pharmaceutical and Medical Device Corporations face continued pressure to ensure staff members in all functional areas are aligning business practices with evolving regulatory compliance frameworks, whether in commercial, research or operational roles. As information continues to become more accessible for employees through pervasive access to technology, compliance trainers must ensure staff fully comprehend the regulations surrounding the use and disclosure of information. For compliance trainers, pushing the limits of traditional training is of essential importance, to ensure staff members truly understand the legal ramifications of actions, to ensure information is retained, as well as ensuring training content and delivery is truly effective.

Topics to Be Addressed:
Interpreting Ongoing Areas of Legal Compliance Concern:
Foreign Corrupt Practices Act
Stark Law
Fraud & Abuse
Designing & Delivering Compliance Training for Executives
Impact of Monitoring vs. Measuring Compliance Data
Adapting Training Based on Perceived & Evaluated Risk


Program Highlights:
Comprehensive Participation from Pharma & Device
Legal Experts On-Site to Clarify and Interpret Laws
Interactive Sessions to Engage & Benchmark

About Exsurco Medical®, Inc.

In 2015, Exsurco Medical moved into its own production facility, a standalone space with a Class 7 cleanroom for assembling and packaging in Wakeman, OH. Exsurco Medical also is registered with the FDA and is ISO 13485:2016 certified.  Exsurco Medical’s mission is to advance incision science to improve the lives of patients in need of the healing power of skin. In 2017, the company launched a new wound debridement and skin grafting medical device, the Amalgatome SD® for use in burn and trauma centers. The product is currently in use in burn centers across the United States.